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An unusual case of synchronous lymphoma 
and adenocarcinoma occurring as a collision 
tumour in the stomach – a case report
Witold KYCLER1, Marek TERESIAK1, Adam ŚLIWIŃSKI2
SUMMARY
:
The occurrence of malignant gastric lymphoma and adenocarcinoma in the same patient is very 
rare. Here we report a case of synchronous gastric carcinoma and gastric lymphoma with a follicular 
growth pattern associated in a 73-year-old man. Preliminary diagnosis gastric tumour was suggested 
so laparotomy was performed for the purpose of treatment resection of the stomach. In the operation 
fi eld, there was a main lesion spreading through the whole of the stomach and additional multiple 
lymph node enlargements at the hepato-duodenal, retro-pancreatic and the para-aortic lymph nodes. 
A short-term intraoperative examination of one of the metastatic lymph nodes showed lymphoma 
of the stomach. Palliative total gastrectomy Roux-en-Y was performed. Finally the pathology of the 
specimen revealed two different collided tumours: adenocarcinoma solidum and non-Hodgkin’s lym-
phoma malignum with follicular growth pattern. Following surgery and chemotherapy, the patient is 
now in a disease progress state. 
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BACKGROUND
The occurrence of malignant gastric lym-
phoma and adenocarcinoma in the same pa-
tient is very rare [1, 2]. Adenocarcinoma of 
the stomach is still one of the most common 
malignancies whereas primary gastric lym-
phoma is relatively uncommon, occurring in 
only 1–7% of all malignant neoplasms of the 
stomach [1]. In the literature in such synchro-
nously observed cases the following lympho-
matous components were reported: superfi cial 
spreading low grade mucosa associated lym-
phoid tissue (MALT), mass-forming immuno-
blastic lymphoma, diffuse infi ltrating T-cell 
pleomorphic small cell lymphoma and diffuse 
large cell type of B cell origin lymphoma [1]. 
Helicobacter pylori infection is considered 
to be associated with development of these 
double malignancies [3–8]. In many such syn-
chronously observed cases lymphomas may 
precede carcinogenesis, while prognosis ap-
pears to be more closely associated with the 
adenocarcinoma than the lymphoma [1]. This 
phenomenon is probably connecting with the 
fact that more of the lymphomas are usually 
histologically low grade. Only a few reports 
have described cases of synchronous adeno-
carcinoma associated with low grade B-cell 
lymphoma of mucosa-associated lymphoid tis-
sue (MALT) of the stomach [8–23]. However, 
reports of other types of malignancies syn-
chronously discovered with gastric carcinoma 
are rather unique. Sung Ha Park et al. [24] re-
ported a single case of gastric carcinoma with 
a synchronously discovered non-Hodgkin’s 
lymphoma diffuse large cell type (B-cell) 
but not involving the gastrointestinal tract. 
Nishino N et al. [25] reported synchronously 
non-Hodgkin’s diffuse large cell type (B-cell) 
and adenocarcinoma occurring as a collision 
tumour in the stomach. 
AIM
Here we report our observations regarding 
an unusual case of synchronous gastric carci-
noma and gastric lymphoma with a follicular 
growth pattern associated.  
CASE REPORT
In February 2004, a 73-year-old man was ad-
mitted to the Great Poland Cancer Centre at 
the 2nd Department of Oncological Surgery, 
Poznań. Before that he had suffered from peri-
odic epigastric pain, weakness, periodic vom-
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iting, loss of appetite and tiredness, but he did 
not complain of fever or night sweats. In the 
preliminary diagnosis a gastric tumour was 
suspected and appropriate diagnostic proce-
dures were applied. Gastrofi broscopy showed 
a lesion infi ltrating the corpus of the stomach. 
Histological examination revealed carcinoma 
solidum ventriculi. X-ray of the upper diges-
tive tract showed an ulcero-infi ltrative mass 
lesion in the corpus of the stomach; the car-
diac region, fornix and antrum were normal. 
The patient was directed to surgery. After he 
was admitted to the 2nd Department of Onco-
logical Surgery presurgical exams were or-
dered. Haematological and biochemical tests 
and x-ray chest examination were normal. 
Abdominal ultrasound showed enlargement of 
the lymph nodes in the epigastric region and 
enlarged infi ltrated stomach wall. There were 
no signs of metastatic disease in the abdomen. 
We recommended laparotomy and consequent-
ly, after the patient had agreed, he underwent 
an operation. In the operation fi eld, there was 
no evidence of metastatic lesions in the liver 
or peritoneum. The main lesion of the stom-
ach was an ulcero-infi ltrative mass tumour 
spreading through the whole of the stomach 
and there were also multiple lymph node en-
largements at the hepato-duodenal, retro-
pancreatic and the para-aortic lymph nodes. 
A short-term intraoperative examination of 
one of the metastatic lymph nodes suggested 
lymphoma. Palliative total gastrectomy Roux-
en-Y oesophago-jejunostomy with end-to-side 
anastomosis, and distal jejuno-jejuno anasto-
mosis and lymphadenectomy of the remain-
ing enlarged lymph nodes was performed (D2 
dissection). The postoperative course was un-
eventful and the patient was discharged on the 
13th day after the surgery.
The pathological analysis of the specimen 
described the lesion of the stomach as a poorly 
differentiated adenocarcinoma infi ltrating the 
whole gastric wall and extending to the serosa 
and perigastric lipid tissue. The pathology 
also showed the collision areas of the two neo-
plastic components. Near the infi ltrated poor-
ly differentiated adenocarcinoma there were 
massive lymphocyte components consisting of 
small cells with a follicular growth pattern. It 
was revealed to be a lymphoma infi ltrating the 
perigastric lipid tissue. Regional lymph node 
examination revealed lymphoma in 12 of 102 
nodes. There was no evidence of adenocarci-
noma metastases. An immunohistochemical 
study on paraffi n-embedded tissue showed: 
CAM 5.2+, CK7+, CK20-, and Ki67 positive 
in 60% of nuclei of the adenocarcinoma cells. 
The pattern of lymphoma immunohistochemi-
cal staining was: CK-, CD20+, CD79a+, bcl2+, 
CD3-, CD30- and fi nally Ki67 positive in a 
few nuclei of the lymphoma cells. The fi nal 
histopathological diagnosis was: 1) Carcino-
ma solidum adenoides (CAM 5.2+, CK7+), 2) 
Lymphoma malignum folliculare G1 (CD20+, 
CD79a+, bcl2+).
The patient was directed to radical COP 
chemotherapy course with Encorton p.o., 
Endoxan i.v. and Vincristin i.v. according to 
standard procedure at the Department of 
Chemotherapy, Great Poland Cancer Centre. 
After that he underwent a bone marrow bi-
opsy which revealed 30% of lymphoma cells 
in bone marrow. There were palpable ingui-
nal nodes. The patient completed 8 cycles of 
COP chemotherapy for treatment of the lym-
phoma. In September 2004 during examin-
ing of the abdomen direct [RA1] tenderness 
of the epigastric area was noted. There were 
no palpable lymph nodes in the cervical, su-
praclavicular, axillary or inguinal areas. The 
computer tomography showed a solid hetero-
geneous tumour localized near the visceral 
trunk. There was evidence of invasions of the 
tumour to the pancreas, spleen, spleen vein, 
transverse colon, ileum bowels and the up-
per part of the right kidney. Gastrofi broscopy 
showed no evidence of disease recurrence. 
The patient underwent fi ne needle biopsy 
under computer tomography control. Micro-
scopic examination revealed poorly differen-
tiated adenocarcinoma cells. Next the patient 
underwent palliative 5FU+Leucovorin LF1 
chemotherapy course with Fluorouracil i.v. 
and Leucovorin i.v. in standard doses (Fluo-
rouracil 3750, Leucovorin 185 mg in 1 week 
cycle). The patient fi nished 4 cycles of pal-
liative chemotherapy for treatment of the 
recurrent adenocarcinoma. The patient was 
under symptomatic and palliative treatment 
and he is still being treated at the Great Po-
land Cancer Centre as an outpatient. The last 
checkup was noted in April 2005. Systematic 
progress of recurrent carcinoma and consis-
tent worsening of living conditions have been 
observed.
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DISCUSSION
The occurrence of primary multiple malig-
nancies arising from different tissue in the 
same organs and patients is very rare [2]. 
There have not been many case reports of 
other types of malignancies synchronously 
associated with gastric adenocarcinoma, es-
pecially occurrences in the same organs. In 
the reported synchronously observed cases 
we found in the literature such lymphoma-
tous components as: superfi cial spreading 
low grade mucosa associated lymphoid tissue 
(MALT), mass-forming immunoblastic lym-
phoma, diffuse infi ltrating T-cell pleomorphic 
small cell lymphoma, diffuse well-differenti-
ated lymphocytic lymphoma and diffuse large 
cell type of B cell origin lymphoma (non-Hodg-
kin’s lymphoma) [1, 9, 8, 24, 26, 27]. There is 
only one non-Hodgkin’s lymphoma (diffuse 
large cell type (B-cell)) [24]. Non-Hodgkin’s 
lymphomas have been classifi ed by several 
different systems over the past 30 years. The 
newer system is called the Revised European 
American Lymphoma (REAL) classifi cation 
and has been recommended for use [28]. In 
our case the synchronously-discovered ma-
lignant lymphoma involved the stomach, the 
lymph nodes of gastric curvatures and local-
ized near the visceral trunk. Bone marrow bi-
opsy showed 30% malignant lymphoma cells. 
Chest examination showed that the lymphoma 
did not involve the lung or the mediastinum. 
The pathology revealed a low-grade lympho-
ma but the ‘stage’ was described as CS IVE be-
cause of extranodal standed for and affected 
the bone marrow (Lugano staging system). A 
controversy concerned the diagnosis of undif-
ferentiated small cells that frequently turn 
out to be undifferentiated carcinoma or high 
grade malignant lymphomas. An immunohis-
tochemical study showed positive staining for 
CD20, CD79a, bcl2 and negative for CK, CD3 
and CD30 in the lymphoma cells. Some cases 
of anaplastic cell lymphoma and Hodgkin’s 
disease express keratin but in most cases 
(like this one) keratin antibodies distinguish 
lymphoma and anaplastic carcinoma [24, 29]. 
In our case, expression of keratin was ob-
served in cells from the part of the mass with 
adenocarcinoma infi ltrating (CAM 5.2, CK7) 
but not in cells from lymph nodes and tumour 
lymphoma. Moreover, in lymph cells, only B-
cell specifi c surface markers such as CD20 
and CD79a were expressed. Bcl-2 protein was 
positive but differences between adenocarci-
nomas and lymphomas were not statistically 
signifi cant in some reports (70% for lympho-
mas and 30% for adenocarcinomas) [29, 30]. 
Immunophenotyping markers makes it easy 
to differentiate lymph node B-cell lymphoma 
and gastric carcinoma. Immunohistochemi-
cally, the Ki-67 labelling indicated (a few per-
cent) signifi cantly lower proliferative activity 
of the lymphoma than the adenocarcinoma 
(60%) [1]. This phenomenon was probably 
due to the fact that the lymphoma in our case 
was histologically low grade. According to 
the published data we know that more syn-
chronous and metachronous lymphomas are 
histologically low grade [1]. Nakamura et 
al. [1] additionally found that the size of the 
lymphomas was signifi cantly larger than that 
of adenocarcinomas and the depth of inva-
sion also tended to be deeper in lymphomas 
than adenocarcinomas. In conclusion the 
author suggested that lymphomas preceded 
the carcinogenesis. Finally in our case the 
histopathological diagnosis was follicular 
lymphoma. In the REAL classifi cation, fol-
licle centre lymphomas (follicular centre cell 
lymphomas with a follicular growth pattern) 
are one of the more common non-Hodgkin’s 
lymphomas. They affl ict almost exclusively 
adults, particularly the middle-aged and el-
derly. They are of B-cell lymphocyte origin. 
Because the small-cleaved cells of follicu-
lar lymphomas know how to circulate in the 
blood, patients usually present with dissemi-
nated lymphadenopathy. Nonetheless these 
lymphomas have a better prognosis than 
higher grade lymphomas. 
Due to the lack of any long-term follow-up 
observations the prognosis of patients with 
double primary gastric lymphoma and ad-
enocarcinoma is unknown. Nakamura et al. 
[1] suggested that the survival probability 
appeared to be similar to that for gastric ad-
enocarcinoma. These results, in addition to 
the fact that many of the lymphomas were low 
grade with lower MIB-1 index, suggest that 
prognosis depends on the behaviour of the ad-
enocarcinoma rather than the lymphoma. In 
our case the adenocarcinoma was a poorly dif-
ferentiated carcinoma in clinical stage II with 
poor clinical prognosis. Surgical treatment 
of gastric cancer has been universally recog-
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nized as the most effective way of treatment. 
However, curative resection of cases in stage 
III and IV and poorly differentiated carcino-
ma results only in an average survival period, 
little more than of patients without operation 
[31].
The advisability of surgical treatment for 
primary multiple neoplasms seems to be in-
disputable. A one-stage operation to excise 
both malignant tumours at the same time is 
possible. Treatment strategies for extranodal 
non-Hodgkin’s lymphoma are well established, 
but there still remains controversy regarding 
the optimal approach, particularly for gastric 
lymphoma [32, 33]. Surgery, radiotherapy and 
chemotherapy have been used alone or in vari-
ous combinations.     
In our opinion, which is shared by many au-
thors, in order to increase the early diagnosis 
of an early stage carcinoma and thus prolong 
patients’ lives, or even cure them completely, 
it is essential to identify high risk patients, 
especially with primary carcinoma or other 
types of malignancies recognized during the 
actual diagnosis or in the past. This group of 
patients needs to receive adequate treatment, 
and ought to be continuously monitored after 
the surgery. According to the literature data, 
lymphoma may precede the development of 
adenocarcinoma in many of the synchronous 
cases [1]. Helicobacter pylori infection is also 
thought to play an important role in the patho-
genesis of these double malignancies [3-8]. 
Prophylactic endoscopy and Helicobacter py-
lori eradication are necessary in order to in-
crease early diagnosis of the early stage and 
to identify high risk patients. 
CONCLUSIONS
Finally the conclusion is that the stage and 
clinical progression of the adenocarcinoma 
and lymphoma are decisive, but results ap-
pear to be similar to those for gastric adeno-
carcinoma.   
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